How to Use Omics Results in the Management of Lung Cancer?

21 Nov 2026 09:30 09:45
Kwun Fong Speaker Australia
Omics (Genomics, Proteomics, and Multi-Omics) “omics” refers to the large-scale study of biological molecules in a tumor, including its DNA (genomics), RNA (transcriptomics), and proteins (proteomics). Omics can be considered essential in lung cancer for several reasons: • Precision Medicine and Targeted Therapy. Lung cancer is driven by diverse genetic mutations. Genomic profiling allows doctors to identify specific driver mutations (such as EGFR, ALK, ROS1, or BRAF) and match patients to targeted drugs as their effectiveness is dependent on the present of mutations. • Biomarker Discovery. Integrating multiple layers of omics data (multi-omics) can discover new biomarkers that predict how the behaviour of a lung cancer. • Overcoming Drug Resistance. Lung cancers can adapt and becomes resistant to treatment. Omics technologies can reveal how cancer cells adapt and change, thus revealing potential new actionable pathways.